Clinical Trials Logo

PSA Level Greater Than Ten clinical trials

View clinical trials related to PSA Level Greater Than Ten.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03581500 Active, not recruiting - Clinical trials for Prostate Adenocarcinoma

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer

Start date: February 6, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well hyperpolarized carbon C 13 pyruvate magnetic resonance spectroscopic imaging works in predicting treatment response in patients with prostate cancer. Hyperpolarized carbon C 13 pyruvate magnetic resonance spectroscopic imaging may help to accurately predict how prostate cancer patients will respond to standard therapy (abiraterone and apalutamide).